DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mapracorat
Mapracorat
(12) Patent Application Publication (10) Pub. No.: US 2017/0152273 A1 Merchant Et Al
W W W .Bio Visio N .Co M New Products Added in 2020
Stems for Nonproprietary Drug Names
Review Article Barrier-Restoring Therapies in Atopic Dermatitis: Current Approaches and Future Perspectives
(12) Patent Application Publication (10) Pub. No.: US 2016/0235763 A1 Budunova Et Al
Emmett Cunningham, Jr., M.D., Ph.D., M.P.H
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Selective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads
Linker Payload Contribution in GR Activation of Steroid-ADC As Tested in HEK293/PRLR/GRE-Luc Cells
Efficacy and Safety of Fixed-Dose Combination Calcipotriol/ Betamethasone Dipropionate Foam for the Treatment of Psoriasis
WHO Drug Information Vol
WO 2016/051188 Al 7 April 2016 (07.04.20 16) W P O P C T
Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?
WO 2013/169647 Al 14 November 2013 (14.11.2013) P O P C T
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0169224 A1
The Hunt for Dry Eye Instigators
Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, Inhibits Hyperosmolar-Induced Cytokine Release and MAPK Pathways in Human Corneal Epithelial Cells
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Top View
Anti-Inflammatory Drugs Amy J
Clinical Study Synopsis
Skin Diseases Affecting Americans
PAREXEL Bioanalytical Division Offers a Wide Range of Bioanalytical Services
SPADY-DISSERTATION-2019.Pdf (10.61Mb)
Clode 2016-BSC-Anti
The Different Facades of Retinal and Choroidal Endothelial Cells in Response to Hypoxia
Sample Case Report 4
(12) United States Patent (10) Patent No.: US 8,765,725 B2 Cavanagh Et Al
Glucocorticoid Receptor
A Selective Activator of the Glucocorticoid Receptor with Anti-Inflammatory and Anti-Cancer Activity
A Murine Model of Glucocorticoid Myopathy Alleviation Using Androgen Therapy
Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, Inhibits Hyperosmolar-Induced Cytokine Release and MAPK Pathways in Human Corneal Epithelial Cells
A Randomized Prospective Open Label Comparative Study of Olopatadine with Sodium Cromoglycate in Allergic Conjunctivitis
Drug Repurposing Compound Library (96-Well)
The Glucocorticoid Receptor Agonistic Modulators Cpdx and Cpdx-D3 Do Not Generate the Debilitating Effects of Synthetic Glucocorticoids
Endocrinology Compound Library (96-Well)
(SEDIGRAM) That Are Effective Against Acute Inflammation
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Anti-Allergic Effects of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, in Human Conjunctival Fibroblasts and Epithelial Cells
( 12 ) United States Patent ( 10 ) Patent No .: US 10,954,263 B2 Cavanagh Et Al